Editorial: Advances in pharmacotherapy for alcohol use disorder: from mechanisms to clinical interventions.

Front Pharmacol

Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA, United States.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12394971PMC
http://dx.doi.org/10.3389/fphar.2025.1671114DOI Listing

Publication Analysis

Top Keywords

editorial advances
4
advances pharmacotherapy
4
pharmacotherapy alcohol
4
alcohol disorder
4
disorder mechanisms
4
mechanisms clinical
4
clinical interventions
4
editorial
1
pharmacotherapy
1
alcohol
1

Similar Publications

Picocyanobacteria in the Chesapeake Bay: isolation, diversity, and adaptation.

Mar Life Sci Technol

August 2025

Institute of Marine and Environmental Technology, University of Maryland Center for Environmental Science, Baltimore, MD 21202 USA.

Tiny unicellular cyanobacteria or picocyanobacteria (0.5-3 µm) are important due to their ecological significance. Chesapeake Bay is a temperate estuary that contains abundant and diverse picocyanobacteria.

View Article and Find Full Text PDF

Diverse marine species convert methylphosphonate to methane.

Mar Life Sci Technol

August 2025

Frontiers Science Center for Deep Ocean Multispheres and Earth System, and College of Marine Life Sciences, Ocean University of China, Qingdao, 266003 China.

Unlabelled: Microbial degradation of methylphosphonate (MPn) is an important pathway contributing to the 'methane paradox' in the oxic ocean. spp. are suggested to participate in this process.

View Article and Find Full Text PDF

Advancing ecological and environmental biology research.

Mar Life Sci Technol

August 2025

The Key Laboratory of Mariculture, Ministry of Education, Fisheries College, Ocean University of China, Qingdao, 266003 China.

View Article and Find Full Text PDF

Annually, millions of humans and animals suffer from chronic and acute pain, creating welfare and quality of life concerns for both humans and animals who suffer this pain. In developing new therapeutic approaches, the challenge is to accurately measure this pain to ascertain the efficacy of novel therapeutics. Additionally, there is a need to develop new and effective analgesic options that may offer alternatives to using opioids that contribute to the opioid epidemic.

View Article and Find Full Text PDF